Neotac Pharmasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-12-18
Share capital
5 000,00 PLN
Registered address
ul. Królowej Jadwigi 148A/1a, 30-212 Kraków, Poland
Electronic delivery address
AE:PL-96740-22937-VTCGI-28

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 322 days for 2021).

  • 202509/07/2026
  • 202413/06/2025
  • 202316/07/2024
  • 202223/06/2023
  • 202102/06/2023
  • 202007/03/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 668.13kMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD -143.02kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 679.80kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 147.44kMedianUSD 883.09kAverageUSD 31.39m

Authorized Representatives

Andrzej Charewicz – Management Board Member
Tomasz Gomulec – President of the Management Board
Janusz Piotr Sikora – Management Board Member
Piotr Konop – Attorney-in-fact (sole)

Manner of representation

The company’s declarations of will may be made by two members of the company’s management board acting jointly, or by one member of the company’s management board together with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Janusz Piotr Sikoraage 60
10$135.0610%
90$1,215.5690%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-01-04.

  • mBank
    38 1140 1081 0000 4607 0500 1002
  • mBank
    65 1140 1081 0000 4607 0500 1001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

FAQ

Last updated: 2026-07-15